Metallothionein Lower Under-Expression in Benign Tumors than That in Malignant Tumors: Systematic Review Article and Meta-Analysis.
Background: Metallothionein (MT) manifests varying expression levels in carcinomas, and they may be considered as valuable cell cancerization biomarkers for diagnosis of patients with cancers. A meta-analysis was conducted to evaluate comprehensively the MT expression difference in various benign tu...
| Publicado en: | Iranian Journal of Public Health Vol. 43; no. 6; pp. 696 - 705 |
|---|---|
| Autores principales: | , , , , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Tehran University of Medical Sciences
Jun2014
|
| Acceso en línea: | Ver este registro en EBSCOhost |